APA (7th ed.) Citation

Campochiaro, P. A., Brown, D. M., Pearson, A., Chen, S., Boyer, D., Ruiz-Moreno, J., . . . Green, K. (2012). Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology (Rochester, Minn.), 119(10), 2125. https://doi.org/10.1016/j.ophtha.2012.04.030

Chicago Style (17th ed.) Citation

Campochiaro, Peter A., et al. "Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema." Ophthalmology (Rochester, Minn.) 119, no. 10 (2012): 2125. https://doi.org/10.1016/j.ophtha.2012.04.030.

MLA (9th ed.) Citation

Campochiaro, Peter A., et al. "Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema." Ophthalmology (Rochester, Minn.), vol. 119, no. 10, 2012, p. 2125, https://doi.org/10.1016/j.ophtha.2012.04.030.